Cannabis businesses operate in a complex and challenging tax environment primarily influenced by Internal Revenue Code (IRC) Section 280E. This section specifically prohibits deductions for ordinary and necessary business expenses related to trafficking controlled substances, including cannabis. As a result, cannabis businesses face significantly higher taxable income levels and increased federal tax liabilities compared to other industries.
Accurate tax filing is crucial for cannabis operators to minimize the risk of audits, penalties, and excessive tax burdens. Mistakes or missed opportunities in previous year filings can have a significant impact on a business’s financial health. When correcting these errors or taking advantage of new deductions allowed by recent regulatory changes, it becomes essential to file an amended cannabis business tax return.
This article serves as a practical guide on how to handle a cannabis business amended tax return: when and why to file one. It addresses:
- The unique cannabis tax challenges stemming from IRC Section 280E.
- Situations that require filing an amended return.
- The relationship between amended returns and ongoing 280E restrictions.
- A risk/benefit analysis tailored for cannabis operators considering retroactive adjustments.
By understanding the strategic considerations behind amending past returns, cannabis businesses can optimize their tax outcomes without triggering IRS issues. This clear and authoritative guidance on the topic promotes compliance while enhancing profitability in this highly regulated industry.
Understanding Cannabis Business Tax Challenges
Cannabis businesses face unique tax challenges primarily due to IRC Section 280E. This provision was enacted to prevent deductions or credits for any amounts spent on trafficking controlled substances, directly impacting cannabis businesses because marijuana is classified as a Schedule I substance at the federal level. As a result, cannabis operations are unable to deduct ordinary and necessary business expenses that other industries can typically claim.
Impact of IRC Section 280E on Cannabis Taxation
1. Disallowance of Deductions
Section 280E prohibits cannabis businesses from deducting common operating costs such as:
- Rent
- Utilities
- Employee salaries (excluding production staff)
- Marketing expenses
- Legal fees
These expenses, known as selling, general & administrative expenses (SG&A), are broadly categorized and cannot be deducted under this provision.
2. Taxable Income Inflation
Since these ordinary expenses cannot be deducted from taxable income, cannabis operators end up facing significantly higher tax burdens compared to non-cannabis businesses with similar revenue profiles. This leads to compressed profit margins and increased capital requirements to meet tax obligations.
3. Limited Exceptions
The only major cost category that can still be deducted under Section 280E is the cost of goods sold (COGS). This includes direct costs associated with producing or acquiring inventory—such as raw materials, labor directly involved in production, and manufacturing overhead that can be capitalized into inventory costs.
Distinguishing COGS from Disallowed SG&A Expenses
It’s crucial for cannabis businesses to correctly separate their COGS from SG&A expenses in order to comply with IRC Section 280E and minimize taxable income:
| Expense Category | Treatment Under IRC Section 280E |
| Cost of Goods Sold (COGS) | Allowed as deductible; reduces taxable income. |
| Selling Expenses | Disallowed; include advertising, sales commissions. |
| General & Administrative | Disallowed; include office rent, utilities, administrative salaries. |
The IRS closely examines this classification. Misallocating expenses between COGS and SG&A can lead to audits or penalties. For instance, labor costs directly related to cultivation and harvesting may qualify for COGS treatment, but costs associated with sales staff or administrative personnel do not.
Consequences for Cannabis Businesses
Here are some consequences that cannabis businesses may face due to the limitations imposed by IRC Section 280E:
- Elevated Effective Tax Rates: As a result of these restrictions, cannabis companies often report taxable incomes that are much higher than their actual profits once disallowed deductions are taken into account.
- Cash Flow Constraints: Higher tax liabilities leave less cash flow available for reinvestment or growth in operations.
- Complex Accounting Practices: It becomes essential for cannabis businesses to maintain detailed financial records in order to support proper expense classification and withstand IRS examinations.
Understanding these fundamental cannabis tax limitations under IRC Section 280E is critical before addressing opportunities presented by recent regulatory changes such as DOJ reclassification and potential amended return filings.
The DOJ Reclassification and Its Tax Implications
The April 2026 DOJ marijuana reclassification represents a pivotal shift in federal cannabis policy. This change officially moved FDA-approved and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act. The reclassification fundamentally alters the tax landscape for qualifying medical cannabis businesses, creating new opportunities and challenges tied to federal tax compliance.
Key Features of the DOJ Reclassification
1. Schedule I vs Schedule III Distinction
Schedule I substances are considered to have no accepted medical use and a high potential for abuse, resulting in stringent regulatory controls and significant tax restrictions under IRC Section 280E. Schedule III substances, by contrast, are recognized as having accepted medical uses with lower potential for abuse, allowing more favorable treatment under federal tax law.
2. Medical Cannabis Deductions Expanded
With this reclassification, qualifying medical cannabis operators may now deduct ordinary and necessary business expenses that were previously disallowed due to Section 280E’s prohibition on deductions for trafficking controlled substances classified as Schedule I. These expenses include selling, general and administrative (SG&A) costs such as rent, utilities, payroll, marketing, insurance premiums, and professional fees.
3. Cost of Goods Sold (COGS) Remains Crucial
While COGS deductions were always permitted under Section 280E, the expansion now enables a comprehensive set of business expenses to be deducted by medical cannabis businesses falling within the new Schedule III classification. This adjustment dramatically reduces taxable income and lowers effective tax rates compared to prior years.
Continued Restrictions on Recreational Cannabis
Recreational cannabis remains classified as Schedule I despite the DOJ’s rescheduling of certain medical marijuana products. This distinction means:
- Recreational cannabis operators continue to face full application of IRC Section 280E restrictions.
- Deductions remain limited predominantly to COGS without allowance for ordinary business expenses.
- Tax liabilities for recreational businesses stay elevated relative to their medical counterparts benefiting from the reclassification.
Practical Tax Implications
The DOJ marijuana reclassification compels medical cannabis businesses to reassess historical tax filings. Prior years’ returns may have overstated taxable income by excluding deductible expenses now recognized post-rescheduling. The ability to file amended returns claiming these deductions introduces potential cash flow improvements through refunds or reduced future payments.
Tax planning strategies must differentiate between:
- Medical cannabis entities eligible under the new Schedule III status.
- Recreational cannabis businesses still constrained by Schedule I classifications.
Navigating this bifurcated tax framework demands precision in classification and documentation to optimize deductions without running afoul of IRS regulations.
When Should Cannabis Businesses File an Amended Tax Return?
Filing an amended tax return for cannabis businesses requires careful evaluation of amended tax return timing and the specific circumstances that justify such action. The primary triggers for submitting an amended return include:
1. Correction of prior-year mistakes
Errors in previous filings, such as misclassification of expenses or incorrect application of IRC Section 280E, must be rectified to align reported taxable income with accurate financial data. These corrections can have a significant impact on tax liabilities and cash flow.
2. Claiming new deductions enabled by rescheduling benefits
The April 2026 DOJ reclassification allows qualifying medical cannabis businesses to deduct ordinary and necessary business expenses previously disallowed under Section 280E. Filing amended returns retroactively captures these deductions, generating potential refunds or reducing outstanding tax obligations.
A practical approach to how to handle a cannabis business amended tax return involves a thorough assessment of eligibility criteria based on the cannabis product’s classification:
For Medical Cannabis Operators
Eligible to file amended returns reflecting expanded deductions due to the shift from Schedule I to Schedule III status. This group can pursue retroactive relief for cannabis taxes by incorporating newly deductible selling, general, and administrative (SG&A) expenses.
For Recreational Cannabis Businesses
Continue to face limitations under Section 280E because recreational marijuana remains classified as Schedule I. Amended returns in this category generally focus on correcting genuine prior-year mistakes rather than claiming rescheduling benefits.
The decision matrix for filing an amended return should integrate:
- Verification of medical vs recreational status — Confirm that the business qualifies under the new regulatory framework permitting expanded deductions.
- Identification and documentation of prior errors — Locate discrepancies or omissions in original filings that materially affect taxable income.
- Calculation of potential tax savings — Quantify the impact of claiming retroactive relief versus risks associated with IRS scrutiny.
- Review of filing deadlines and statute limitations — Ensure amendments fall within allowable timeframes established by the IRS for refund claims.
This methodical evaluation prevents unnecessary exposure while leveraging opportunities created by recent legal developments. The nuanced interaction between amended returns and IRC Section 280E demands precise execution tailored to each cannabis enterprise’s operational profile.
How Amended Returns Interact with IRC Section 280E Limitations
Navigating IRC Section 280E interaction when filing amended cannabis business tax returns requires precise understanding of the differential treatment between medical and recreational cannabis under current law. The DOJ’s reclassification affects only qualifying medical marijuana businesses, permitting them to claim deductible expenses after rescheduling that were previously disallowed. Recreational cannabis operators remain fully subject to the longstanding restrictions of Section 280E.
Medical Cannabis and Expanded Deductibility
The shift from Schedule I to Schedule III for FDA-approved and state-regulated medical cannabis enables eligible businesses to deduct ordinary and necessary expenses beyond Cost of Goods Sold (COGS). These expenses typically include:
- Selling, General & Administrative (SG&A) costs
- Rent, utilities, salaries, marketing, and professional fees
- Depreciation and amortization related to business operations
When amending returns for prior years affected by this reclassification, a detailed reconciliation process is necessary:
- Identify specific expenses previously disallowed solely due to Section 280E.
- Reclassify these amounts as deductible operating expenses in alignment with the new legal framework.
- Adjust taxable income accordingly, ensuring accurate documentation supports each deduction.
Recreational Cannabis and Continued Limitations
Recreational cannabis remains classified as a Schedule I substance under federal law. Therefore, amended returns must comply with ongoing Section 280E restrictions, which limit deductions strictly to COGS. Attempting to claim broader SG&A deductions on amended returns for recreational cannabis businesses risks triggering IRS audits or denial of refunds.
Key compliance considerations include:
- Maintaining robust separation between COGS and non-deductible expenses in accounting records.
- Avoiding commingling of medical versus recreational product expenses if both are operated under one entity.
- Documenting clear allocation methods for shared costs when applicable.
Compliance Considerations Across All Cannabis Businesses
Filing amended returns in the cannabis sector demands heightened attention to IRS expectations due to the complex regulatory environment. Compliance measures should include:
- Detailed schedules supporting each adjustment related to deductible expenses post-rescheduling.
- Comprehensive tracking of product classification (medical vs recreational) linked directly to expense categories.
- Proactive consultation with tax advisors specialized in cannabis taxation law for tailored strategies mitigating audit risks.
“How amended returns interact with 280E hinges on accurate categorization of business activities and strict adherence to updated legal boundaries defining deductible costs.”
Accounting systems must be adapted to reflect these distinctions clearly, particularly when preparing amended filings covering multiple tax years affected by changing regulations.
Integrating these principles safeguards cannabis businesses seeking retroactive tax relief while maintaining compliance with IRC Section 280E’s evolving landscape. This strategic approach minimizes exposure while maximizing legitimate deductions enabled by rescheduling developments.
Risk/Benefit Analysis Before Filing an Amended Cannabis Tax Return
Deciding whether to file an amended tax return for a cannabis business is not straightforward. It requires careful consideration of the risks and benefits involved. The complex rules surrounding cannabis taxation, especially after the Department of Justice reclassification, add another layer of difficulty to this decision-making process. It’s crucial to weigh these complexities against the potential financial benefits that may arise from filing an amended return.
IRS Audit Risk and Increased Scrutiny
When a cannabis business files an amended tax return seeking retroactive relief based on the new Schedule III classification for medical cannabis, it automatically attracts more attention from the Internal Revenue Service (IRS). This is because the agency has historically scrutinized cannabis businesses under IRC Section 280E, which disallows certain deductions for businesses involved in illegal activities.
As a result, there is a higher risk of audit when amended filings claim previously disallowed deductions. An audit can have several consequences:
- Lengthy examinations extending multiple years.
- Additional penalties and interest if discrepancies are found.
- Increased documentation requirements, magnifying administrative burdens.
To mitigate this risk, businesses must be prepared for the possibility of an audit by maintaining thorough records and ensuring that all claims made in their tax returns comply with current tax regulations.
Uncertainties Due to Incomplete IRS Guidance on Retroactive Relief
The Treasury Department and IRS have not yet provided detailed procedures or clarifications on how refunds related to rescheduling will be processed retroactively. This lack of guidance creates uncertainty around various aspects such as:
- Eligibility criteria for prior years.
- Acceptable methods to calculate newly deductible expenses.
- How adjustments will impact previous accounting treatments and tax positions.
Taxpayers now face the challenge of interpreting preliminary guidance while also exposing themselves to potential compliance risks. To minimize this exposure, it is advisable to adopt conservative approaches guided by expert interpretation.
Impact on Future Loss Carryforwards Under Sections 382 and 383
Loss carryforwards are important deferred tax assets for many cannabis businesses that are struggling with high effective tax rates due to Section 280E restrictions. However, filing amended returns can trigger limitations under Sections 382 and 383 if there are ownership changes or shifts in accounting methods. This could result in:
- Reduction or disallowance of net operating loss (NOL) carryforwards.
- Limitations on credits related to prior-year tax attributes.
- Complex calculations required to determine allowable usage after the amendment.
Before pursuing amendments that may unintentionally reduce future tax planning flexibility, it is critical to evaluate the potential impact on these valuable tax benefits.
Professional CPA Advisory: Essential for Effective Decision-Making
Amending cannabis business tax returns involves various complexities such as balancing IRS audit risk, navigating incomplete guidance, and preserving tax attributes. To make informed decisions in this process, it is essential to partner with experienced cannabis tax professionals who can provide strategic advice tailored to individual business circumstances.
Firms like The Canna CPAs specialize in:
- Interpreting evolving federal and state cannabis tax regulations.
- Conducting thorough risk assessments specific to each business.
- Designing amendment strategies that optimize deductions without attracting unnecessary IRS attention.
By engaging such expertise, businesses can ensure a disciplined approach that aligns with compliance requirements while maximizing potential benefits from retroactive relief.
Additional Tax Benefits from Rescheduling Beyond Amended Returns
The DOJ’s decision to reclassify FDA-approved and state-regulated medical marijuana from Schedule I to Schedule III opens up a range of tax benefits that were previously unavailable to cannabis businesses. These benefits go beyond the immediate relief provided by filing amended returns, creating strategic opportunities for improved cash flow and tax efficiency.
Key Tax Benefits Now Available for Medical Cannabis Operators:
1. 100% Bonus Depreciation
Medical cannabis businesses eligible for rescheduling benefits can now apply 100% bonus depreciation on qualifying property placed in service. This accelerated depreciation allows full expensing of capital assets such as cultivation equipment, processing machinery, and facility improvements in the first year rather than depreciating over multiple years.
Example: A dispensary investing $1 million in new cultivation technology may deduct the entire amount immediately under bonus depreciation rules, reducing taxable income significantly in the acquisition year.
2. Expanded Section 179 Expensing Limits
Section 179 allows businesses to elect immediate expensing of certain tangible personal property up to specified thresholds. Rescheduled medical cannabis companies qualify for this expanded deduction, providing flexibility alongside bonus depreciation. Unlike bonus depreciation which applies automatically unless elected otherwise, Section 179 requires an explicit election but offers limits that can be strategically utilized depending on asset types and business circumstances.
3. Research & Development (R&D) Expense Deductions
Prior restrictions under IRC Section 280E limited deductions for ordinary business expenses including R&D costs. With rescheduling, medical cannabis operators can immediately deduct research and development expenses necessary for product innovation, extraction methods, or compliance testing. This immediate deduction improves cash flow by reducing current-year taxable income rather than capitalizing and amortizing these costs over several years.
4. Potential Eligibility for R&D Tax Credits
Beyond deductions, qualifying cannabis businesses may pursue federal R&D tax credits designed to incentivize innovation. These credits directly reduce tax liability dollar-for-dollar and can be substantial when developing new strains, improving cultivation techniques, or creating proprietary formulations. Careful documentation and substantiation are essential to support R&D credit claims under IRS scrutiny.
These additional tax benefits integrate with the guidance provided in “How to Handle a Cannabis Business Amended Tax Return: When and Why to File One,” ensuring cannabis operators not only correct prior-year mistakes but also maximize ongoing tax advantages resulting from regulatory changes.
Capitalizing on these incentives requires meticulous accounting practices aligned with evolving IRS rules and a proactive approach toward tax planning. The complexity of combining amended return filings with expanded deductions underscores the necessity of expert CPA consultation specialized in cannabis taxation to safeguard compliance while optimizing financial outcomes.
Step-by-Step Guide to Filing an Amended Cannabis Business Tax Return
Filing amended cannabis business tax returns requires precision, adherence to IRS protocols, and comprehensive documentation. The following steps ensure compliance while maximizing the potential benefits arising from recent rescheduling changes.
1. Determine Eligibility for Amendment
Confirm that your business qualifies for an amended return. Eligible reasons include correcting prior-year tax filing errors and claiming newly available deductions or credits stemming from the DOJ’s reclassification of medical cannabis. Also distinguish whether your operation is a medical cannabis business eligible for expanded deductions or a recreational cannabis entity still subject to Section 280E restrictions.
2. Obtain the Correct IRS Forms
- Use Form 1040X for amended individual tax returns, including sole proprietors engaged in cannabis businesses.
- Use Form 1120X for amended corporate tax returns relevant to cannabis companies structured as corporations.
- Use Form 1065X or the appropriate equivalent when amending partnership returns, depending on entity type.
3. Gather Comprehensive Supporting Documentation
A robust paper trail substantiates all corrections or newly claimed deductions. Collect the following before proceeding:
- Original filed tax return copies and associated schedules.
- Detailed financial statements reflecting corrected income, cost of goods sold (COGS), selling, general & administrative expenses (SG&A), and other relevant adjustments.
- Documentation validating compliance with medical marijuana state regulations qualifying the business under Schedule III criteria.
- Receipts, invoices, payroll records, and contracts related to new deductions or credits, such as R&D expenditures.
- Legal documents confirming changes in classification status or licensing dates aligning with rescheduling timelines.
4. Carefully Complete the Amended Return
Report corrected figures clearly on Form 1040X or Form 1120X, specifying each change line by line. Recalculate tax liabilities factoring in expanded deduction eligibility for medical cannabis operators.
In Part III of Form 1040X, or the corresponding section of Form 1120X, provide a comprehensive written explanation covering the reasons for the amendment and the connection to IRC Section 280E modifications resulting from rescheduling.
5. Attach All Required Schedules and Statements
- Revised Schedules C, E, or K-1 as applicable, reflecting updated income and expense allocations.
- A statement reconciling original return amounts with amended figures.
- Any additional IRS forms supporting new deduction claims, such as Form 4562 for depreciation.
6. Review and Cross-Verify Accuracy
Errors or omissions can trigger audits. Validate mathematical accuracy throughout all forms and attachments, and ensure full consistency between your financial records and the reported data.
7. Submit the Amended Return Within IRS Time Limits
Generally, file amendments within three years from the date the original return was filed or two years from payment of tax, whichever is later. Also consider any applicable state-level amendment filing requirements.
8. Maintain Copies of All Submitted Documentation
Record retention supports future IRS inquiries.
“Maintain complete copies of amended returns along with all supporting documentation for at least seven years due to potential IRS scrutiny specific to cannabis taxation.”
Adhering strictly to these filing steps mitigates risks while leveraging new opportunities presented by federal reclassification efforts. The complexity inherent in navigating IRC Section 280E post-rescheduling demands meticulous preparation backed by professional CPA guidance experienced in cannabis taxation compliance.
Best Practices for Cannabis Businesses Post-Amendment Filing
Cannabis businesses must adopt rigorous ongoing compliance measures following the filing of amended tax returns. The IRS’s intensified scrutiny on cannabis-related tax matters necessitates meticulous attention to recordkeeping and adherence to evolving regulatory standards.
Maintaining Comprehensive Documentation
- Maintain detailed records substantiating all deductions claimed on amended returns, especially those newly allowed due to rescheduling changes.
- Retain invoices, receipts, contracts, payroll records, and internal accounting ledgers that clearly differentiate between cost of goods sold (COGS) and selling, general & administrative expenses (SG&A).
- Establish a centralized document repository accessible for both internal review and external audit purposes.
- Implement a standardized documentation protocol to ensure consistency across reporting periods, facilitating easier verification of deductions.
“Accurate and thorough documentation is the backbone of defensible tax positions in the cannabis industry.”
Regular Review and Adjustment of Accounting Methods
- Continuously evaluate accounting methods for inventory costing—such as FIFO, LIFO, or specific identification—to align with IRS guidance and industry best practices.
- Periodically reassess cost allocation methodologies to ensure proper segregation of deductible expenses from those disallowed under IRC Section 280E for recreational products.
- Engage accounting professionals with cannabis sector expertise for reviews that reflect current regulatory interpretations and judicial rulings affecting tax treatment.
- Update accounting software configurations to capture nuances related to medical versus recreational product lines post-rescheduling.
Proactive Tax Planning Strategies for Cannabis Companies
- Integrate forward-looking tax planning into operational decision-making processes; consider impacts on future loss carryforwards, credits, and depreciation strategies.
- Anticipate potential shifts in IRS policy or additional legislative actions by maintaining flexible accounting structures capable of swift adaptation.
- Leverage insights from periodic tax compliance audits to identify areas for improvement or risk mitigation before subsequent filings.
- Coordinate with CPAs specialized in cannabis taxation to develop tailored strategies maximizing legal deductions while minimizing exposure to penalties or audits.
Recordkeeping Tips Specific to Cannabis Industry Dynamics
- Document all licensing information and state compliance certifications alongside financial records to demonstrate legitimacy and regulatory adherence.
- Track inventory meticulously at each stage—from cultivation through sale—to support accurate COGS calculations crucial under Section 280E constraints.
- Preserve correspondence with tax authorities related to amended returns or rescheduling benefits as part of an audit defense toolkit.
Adhering to these best practices equips cannabis businesses with a robust framework for sustaining compliance after amended return submissions. The complexity inherent in cannabis taxation demands vigilant recordkeeping combined with ongoing strategic review to safeguard profitability while minimizing IRS risks.
Conclusion
Navigating the complexities of cannabis taxation requires a strategic approach based on expert knowledge and careful planning. The guide on How to Handle a Cannabis Business Amended Tax Return: When and Why to File One provides industry operators with essential insights for correcting previous mistakes, conducting a thorough risk/benefit analysis, and understanding how amended returns interact with IRC Section 280E.
Key considerations include:
- Assessing eligibility for rescheduling benefits, particularly distinguishing between medical and recreational cannabis.
- Evaluating risks such as IRS scrutiny, audit triggers, and potential impacts on future tax attributes like loss carryforwards.
- Maintaining accurate documentation to support all deductions claimed post-amendment amid heightened regulatory attention.
- Adapting accounting methods to align with evolving IRS guidance and industry standards.
Engaging professional CPA advisors with specialized expertise in cannabis taxation is essential. Firms like The Canna CPAs provide authoritative counsel tailored to the marijuana industry’s unique tax landscape. Their guidance ensures compliance while maximizing financial outcomes through prudent tax strategies.
Cannabis businesses looking to amend previous returns or optimize tax positions must prioritize expert collaboration, precise execution, and continuous monitoring of regulatory developments. This approach turns complex tax challenges into actionable opportunities for sustained profitability and compliance assurance.
FAQs (Frequently Asked Questions)
What unique tax challenges do cannabis businesses face due to IRC Section 280E?
Cannabis businesses are uniquely impacted by IRC Section 280E, which disallows deductions for ordinary business expenses except for cost of goods sold (COGS). This results in higher taxable income and increased tax liabilities compared to other industries, making accurate tax filing critical.
How does the DOJ’s April 2026 reclassification affect cannabis business tax deductions?
The DOJ’s reclassification of FDA-approved and state-regulated medical marijuana from Schedule I to Schedule III allows qualifying medical cannabis businesses to deduct ordinary and necessary expenses previously disallowed under Section 280E. However, recreational cannabis remains Schedule I, maintaining restrictions under 280E.
When should a cannabis business file an amended tax return?
Cannabis businesses should consider filing an amended tax return to correct prior-year mistakes or to claim new deductions arising from the DOJ’s rescheduling benefits. Eligibility depends on whether the business operates in the medical or recreational cannabis sector and requires careful assessment.
How do amended returns interact with IRC Section 280E limitations for cannabis businesses?
Amended returns must navigate ongoing Section 280E restrictions carefully. While medical cannabis operators may claim expanded deductions post-rescheduling, recreational cannabis businesses remain limited. Compliance considerations are critical to avoid triggering IRS issues during amendments.
What are the risks and benefits of filing an amended cannabis business tax return?
Filing an amended return can provide retroactive relief and access to new deductions but carries risks such as increased IRS audit scrutiny, uncertainties due to incomplete IRS guidance on rescheduling refunds, and potential impacts on future loss carryforwards under Sections 382 and 383. Professional CPA advice is strongly recommended.
What additional tax benefits might medical cannabis businesses gain following rescheduling beyond amended returns?
Following rescheduling, medical cannabis operators may be eligible for new incentives including 100% bonus depreciation, expanded Section179 expensing limits, immediate deduction of research and development expenses, and potential R&D tax credits—offering significant opportunities for tax savings.
